Six Dos and Don’ts of Define-XML
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…
Simona Colucci2024年10月30日
The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
Simona Colucci2024年10月30日
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – 2024年10月30日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in…
Certara2024年10月30日
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
要旨：T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
Renee Fisher2024年10月29日
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…
Renee Fisher2024年10月29日
Early Feasibility Assessment: An Innovative Approach to Gain Confidence in Therapeutic Discovery
In this webinar Josh Apgar, PhD discusses Early Feasibility Assessment (EFA), a quantitative approach to early…
Renee Fisher2024年10月29日
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa. — 2024年10月28日 -- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in…
Danielle Pillsbury2024年10月28日
Pharma Exec: MDMA Therapy for Mental Health Conditions
Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…
Certara2024年10月28日
Adapting Value Stories for Global Healthcare Markets
Explore how to tailor healthcare value stories to global market access strategies, addressing cultural nuances,…
Danielle Pillsbury2024年10月28日
How To Respond to Health Authority Questions
Your biotech company has just submitted the marketing application for your first drug product. It’s…
Certara2024年10月25日
